Albemarle (ALB) Reports Q4 Loss, Beats Revenue Estimates

分组1 - Albemarle reported a quarterly loss of $0.53 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.40, but an improvement from a loss of $1.09 per share a year ago, indicating an earnings surprise of -33.00% [1] - The company posted revenues of $1.43 billion for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 5.80%, and showing an increase from $1.23 billion in the same quarter last year [2] - Albemarle has surpassed consensus EPS estimates three times over the last four quarters, indicating a positive trend in earnings performance [2] 分组2 - The stock has gained approximately 19.2% since the beginning of the year, significantly outperforming the S&P 500's gain of 1.4% [3] - The current consensus EPS estimate for the upcoming quarter is $0.11 on revenues of $1.18 billion, and for the current fiscal year, it is $4.34 on revenues of $5.45 billion [7] - The Zacks Industry Rank for Chemical - Diversified is currently in the bottom 9% of over 250 Zacks industries, suggesting potential challenges for stocks in this sector [8]